Involvement of inflammatory cytokines and nitric oxide in the expression in non-specific resistance to Listeria monocytogenes in mice induced by viable but not killed Mycobacterium bovis BCG

Microbial Pathogenesis

Volumn 22, Issue 2, 1997, Pages 79-88

  Yang, Jianfei ^a   Kawamura, Ikuo ^a   Mitsuyama, Masao ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

BCG; inducible nitric oxide synthase; inflammatory cytokines; Listeria monocytogenes; nitric oxide

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; HOST RESISTANCE; LISTERIA MONOCYTOGENES; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031079754     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1996.0093     Document Type: Article

References (37)

1. 1 Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 1976; 116: 180-3.
2. 2 Simon HB, Sheagren JN. Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity. J Exp Med 1971; 133: 1377-89.
3. 3 Ratliff TL. Role of the immune response in BCG for bladder cancer. Eur Urol 1992; 21 (suppl 2): 17-21.
4. 4 van Dissel JT, Stikkelbroeck JJM, van den Barselaar MT, Sluiter W, Leijh PCJ, van Furth R. Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages. J Immunol 1987; 139: 1665-72.
5. 5 Ruco LP, Meltzer MS. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by PPD in BCG-immune mice. Cell Immunol 1977; 32: 203-15.
6. 6 Czuprynski CJ, Brown JF. Recombinant murine interleukin-1α enhancement of nonspecific antibacterial resistance. Infect Immun 1987; 55: 2061-5.
7. 7 Igarashi K, Mitsuyama M, Muramori K, Tsukada H, Nomoto K. Interleukin-1-induced promotion of T-cell differentiation in mice immunized with killed Listeria monocytogenes. Infect Immun 1990; 58: 3973-9.
8. 8 Bonta IL, Ben-Efraim S. Involvement of inflammatory mediators in macrophage antitumor activity. J Leukoc Biol 1993; 54: 613-26.
9. 9 Amiri P, Locksley RM, Parslow TG, Sadick M, Rector E, Ritter D, Mckerrow JH. Tumour necrosis factor α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 1992; 356: 604-7.
10. 10 Mastroeni P, Skepper JN, Hormaeche CE. Effect of antitumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections. Infect Immun 1995; 63: 3674-82.
11. 11 Buchmeier NA, Schreiber RD. Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci USA 1985; 82: 7404-8.
12. 12 Boockvar KS, Granger DL, Poston RM, Maybodi M, Washington MK, Hibbs Jr JB, Kurlander RL. Nitric oxide produced during murine listeriosis is protective. Infect Immun 1994; 62: 1089-100.
13. 13 Flesch IEA, Kaufmann SHE. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun 1991; 59: 3213-8.
14. 14 Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992; 175: 1111-22.
15. 15 Stuehr DJ, Marietta MA. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-γ. J Immunol 1987; 139: 518-25.
16. 16 Änggård E. Nitric oxide: mediator, murderer, and medicine. Lancet 1994; 343: 1199-206.
17. 17 Assreuy J, Cunha FQ, Epperlein M, Noronha-Dutra A, O'Donnell CA, Liew FY, Moncada S. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol 1994; 24: 672-6.
18. 18 Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TW, Taniguchi T, Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994; 263: 1612-5.
19. 19 Nussler AK, Billiar TR. Inflammation, immuno-regulation, and inducible nitric oxide synthase. J Leukoc Biol 1993; 54: 171-8.
20. 20 Cenci E, Romani L, Mencacci A, Spaccapelo R, Schiafella E, Puccetti P, Bistoni F. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 1993; 23: 1034-8.
21. 21 Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factors-β1 -β2 and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J Immunol 1990; 145: 940-4.
22. 22 Warner RL, Paine R3rd, Christensen PJ, Marletta MA, Richards MK, Wilcoxen SE, Ward PA. Long sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol 1995; 12: 649-61.
23. 23 Yang J, Kawamura I, Zhu H, Mitsuyama M. Involvement of NK cells in nitric oxide production by spleen cells after stimulation with Mycobacterium bovis BCG. Study for mechanism of the different ability between viable and killed BCG. J Immunol 1995; 155: 5728-35.
24. 24 Xiong H, Kawamura I, Nishibori T, Mitsuyama M. Cytokine gene expression in mice at an early stage of infection with various strains of Listeria spp. differing in virulence. Infect Immun 1994; 62: 3649-54.
25. 25 Zhan Y, Cheers C. Differential induction of macrophage-derived cytokines by live and dead intracellular bacteria in vitro. Infect Immun 1995; 63: 720-3.
26. 26 Nakane A, Minagawa E, Kohanawa M, Chen Y, Sato H, Moriyama M, Tsuruoka N. Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections. Infect Immun 1989; 57: 3331-7.
27. 27 Rogers HW, Tripp CS, Schreiber RD, Unaue ER. Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis. J Immunol 1994; 153: 2093-101.
28. 28 Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141: 2407-12.
29. 29 Gregory SH, Wing EJ, Hoffman RA, Simmons RL. Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J Immunol 1993; 150: 2901-9.
30. 30 Szalay G, Hess J, Kaufmann SHE. Restricted replication of Listeria monocytogenes in a gamma interferon-activated murine hepatocyte line. Infect Immun 1995; 63: 3187-95.
31. 31 Samsom JN, Langermans JAM, Groeneveld PHP, van Furth R. Acquired resistance against a secondary infection with Listeria monocytogenes in mice is not dependent on reactive nitrogen intermediates. Infect Immun 1996; 64: 1197-202.
32. 32 Amber IJ, Hibbs Jr JB, Parker CJ, Jonson BB, Taintor RR, Vavrin Z. Activated macrophage condition medium: identification of the soluble factors inducing cytotoxicity and the L-arginine dependent effector mechanism. J Leukoc Biol 1991; 49: 610-20.
33. 33 Drapier JC, Wietzerbin J, Hibbs Jr JB. Interferon-γ and tumor necrosis factor induces the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 1988; 18: 1587-92.
34. 34 Green SJ, Nacy CA, Schreiber RD, Granger DL, Crawford RM, Meltzer MS, Fortier AH. Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect Immun 1993; 61: 689-98.
35. 35 Williams G, Brown T, Becker L, Prager M, Giroir BP. Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am J Physiol 1994; 267 (4 Pt 2): R1020-5.
36. 36 Tsukada H, Kawamura I, Arakawa M, Nomoto K, Mitsuyama M. Dissociated development of T cells mediating delayed-type hypersensitivity and protective T cells against Listeria monocytogenes and their functional difference in lymphokine production. Infect Immun 1991; 59: 3589-95.
37. 37 Kawamura I, Tsukada H, Yoshikawa H, Fujita M, Nomoto K, Mitsuyama M. IFN-γ-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice. J Immunol 1992; 148: 2887-93.